Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 November, 2018 10:23 IST
'Subscribe' to Equitas Holdings IPO: Angel Broking
Source: IRIS | 04 Apr, 2016, 03.04PM
Comments  |  Post Comment

Equitas Holdings (Equitas) is a diversified financial services player with presence across microfinance, vehicle & MSE finance and housing finance. With a humble start in 2007, it has emerged as the fifth largest micro finance player in a short period of time. Equitas is amongst the ten players to have received a small finance bank license from the Reserve Bank of India (RBI). The company has a presence in 11 states through 539 branches, is backed by a strong Management team and with it being the second IPO in the micro finance segment, we expect strong subscription responses to the issue.

Angel Broking has recommended 'Subscribe' to IPO of Equitas Holdings. Commenting on the investment rationale, the stock broker said, ''At the upper band of the offer price Rs 110 the issue is priced at 1.8x its diluted BV of Rs 60 (pre-dilution 2.3x).

The company has decent ROE and ROA of 13% and 3.1%. Though post conversion to a SFB the return ratios might be compressed, while we expect the same to scale up subsequently. We believe the issue is attractively priced looking at the growth options the company offers in the long run. We recommend Subscribe to the issue.''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Suven Life Sciences secures product Patents in Australia and Hong Kong - 13-Nov-2018 10:18
GAIL Gas signs MoU with EESL - 13-Nov-2018 10:14
Lupin launches generic Atovaquone oral suspension in US - 12-Nov-2018 16:06
Zydus Cadila gets USFDAs nod for anti-fungal ointment - 12-Nov-2018 13:40
NHB sanctions Rs 35 bn refinance facility to PNB Housing Finance - 12-Nov-2018 13:17
BHEL commissions 120 MW Pulichintala hydro-electric project - 12-Nov-2018 12:55
Tata Consultancy Services partners with ENGIE Laborelec - 12-Nov-2018 12:52
Lupin gets establishment inspection report for Nagpur unit - 12-Nov-2018 09:56
GAIL fast tracks North East feeder gas pipeline project - 12-Nov-2018 09:43
Biocon's new generic facility in Bengaluru completes inspection - 12-Nov-2018 09:35
Cipla gets USFDA final approval for Valganciclovir tablets - 12-Nov-2018 09:32
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer